Saturday 17 October 2026 Export PHAR’s income statement to Excel — free account

Pharming Group N.V. Sponsored ADR

Pharming Group N.V. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 26.6% from fiscal 2024. In the quarter to June 2026, revenue fell 3.22%, EPS fell 57.1%, free cash flow fell 183.9% and total debt rose 1.55%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.36 0.27 −2.80%

Follow PHAR

Alert me

Market cap: $681.6M
P/E: 62.4×
Fwd P/E: 0.0×
Dividend yield: —
F-score: 5/9
Altman Z: 3.88
Beneish M: −2.78
Dividend safety: n/a

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	1,450.00	441.75	87.58	92.60
P/S ratio Full definition →		2.73	3.24	3.35	2.02
P/FCF ratio Full definition →		18.76	22.56	22.24	21.56
P/Operating CF Full definition →		30.87	113.67	634.83	(76.70)
P/B ratio Full definition →		3.74	4.39	4.61	2.74
Price to Tangible BV Full definition →		7.62	8.60	8.98	5.20
EV/Sales Full definition →		2.54	3.02	3.16	1.86
EV/EBITDA Full definition →		21.93	30.63	29.38	22.26
EV/Operating CF Full definition →		17.25	20.75	20.68	19.42
EV/FCF Full definition →		17.46	21.04	20.95	19.80
Quick Ratio Full definition →		2.39	2.03	2.06	2.31
Current Ratio Full definition →		3.16	2.59	2.63	3.01
Net Debt/EBITDA Full definition →		(3.70)	(8.62)	40.19	(13.93)
Debt/Assets Full definition →		20.76%	19.61%	20.18%	20.91%
Debt/Equity Full definition →		0.37	0.35	0.37	0.36
Asset Turnover Full definition →		0.81	0.84	0.83	0.80
Operating CF/Net income Full definition →		4.27	1.96	(0.37)	(6.04)
Capex/Depreciation Full definition →		(0.03)	(0.08)	(0.08)	(0.03)
Research and Development Expense of Revenue Full definition →		24.05%	30.15%	35.28%	35.81%
Selling, General and Administrative Expense of Revenue Full definition →		52.52%	48.15%	62.85%	48.23%
Intangible Assets out of Total Assets Full definition →		0.28	0.27	0.27	0.27
Share Based Compensation of Revenue Full definition →		3.29%	4.23%	4.45%	3.71%
Graham Net Nets Full definition →		0.07	0.06	0.06	0.11
Graham Number Full definition →		0.93	1.90	3.93	4.14
Earnings Yield Full definition →		0.07%	0.23%	1.14%	1.08%
Free Cash Flow Yield Full definition →		5.33%	4.43%	4.50%	4.64%
Revenue per Share Full definition →		1.43	1.55	0.97	1.69
Operating CF per Share Full definition →		0.47	0.16	0.03	(0.18)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.47	0.15	0.02	(0.18)
Cash per Share Full definition →		2.45	2.61	2.29	2.97
Shareholders Equity per Share Full definition →		3.88	4.02	3.61	5.07
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		3.88	4.02	3.61	5.07
Free Cash Flow Full definition →		31.96	10.44	1.71	(9.74)
Working Capital Full definition →		189.69	183.68	183.17	187.44
Capital Expenditures Full definition →		(0.07)	(0.27)	(0.24)	(0.08)
Net Current Asset Value Full definition →		68.46	76.61	75.11	83.20
EV/EBIT Full definition →		35.06	43.93	41.72	36.83
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		37.67	47.10	44.30	40.10
Other line items
Average Receivables Full definition →		45.90	54.76	53.76	55.15
Average Payables Full definition →		75.43	86.26	86.14	80.35
Average Inventory Full definition →		64.68	60.31	61.96	64.57
Average Assets Full definition →		449.65	449.97	446.27	457.12
Average Common Equity Full definition →		245.22	249.08	242.13	255.02

Fold the line items

Columns are period end dates

Stockrow Weekly